Lymphoma, B-Cell Refractory
1 clinical trials · Condition
◉ Watch Lymphoma, B-Cell Refractory
| Record | Firm | Date |
|---|---|---|
| Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects (NCT00498914) | Astellas Pharma Inc | 2007-06-01 |
Track Lymphoma, B-Cell Refractory automatically
Every clearance here is in the API, with alerts when new ones post.